Table 1.
Risk factors for PV: epidemiological parameters and blood and urine test markers
| PV (+) (n=98) | PV (-) (n=1,123) | p-value | |
|---|---|---|---|
| Age (years) | 54.4±10.7 | 51.1±9.1 | 0.012* |
| Gender ratio (M:F) | 0.63:1 | 1.18:1 | 0.002* |
| BMI (kg/cm2) | 23.6±2.9 | 23.9±2.9 | 0.606 |
| Blood test results | |||
| Hb (g/dL) | 14.0±1.2 | 14.4±1.3 | 0.002* |
| WBC (×109/L) | 5.9±1.6 | 6.1±1.6 | 0.312 |
| Platelets (×109/L) | 249.3±52.8 | 250.1±54.4 | 0.893 |
| BUN (mg/dL) | 13.7±3.7 | 14.2±3.7 | 0.216 |
| Cr (mg/dL) | 0.8±0.2 | 0.8±0.2 | 0.041* |
| Glucose (mg/dL) | 95.0±15.0 | 95.2±15.2 | 0.896 |
| GOT (IU/L) | 22.5±8.9 | 22.7±10.0 | 0.830 |
| GPT (IU/L) | 21.5±19.1 | 22.1±15.0 | 0.770 |
| γ-GTP (IU/L) | 33.8±50.1 | 38.1±50.1 | 0.416 |
| Total cholesterol (mg/dL) | 199.6±37.6 | 197.7±36.3 | 0.642 |
| LDL (mg/dL) | 123.0±24.6 | 122.1±32.5 | 0.864 |
| HDL (mg/dL) | 48.5±11.8 | 47.8±10.3 | 0.594 |
| TG (mg/dL) | 118.3±61.5 | 144.1±122.7 | 0.039* |
| Vitamin D | 18.8±6.7 | 18.8±6.6 | 0.987 |
| ALP (IU/L) | 231.2±70.8 | 221.3±63.8 | 0.187 |
| PTH | 61.7±18.1 | 65.1±21.3 | 0.172 |
| Urine test results | |||
| pH | 5.8±0.9 | 5.7±0.8 | 0.327 |
| SG | 1.02±0.01 | 1.02±0.01 | 0.050 |
| Protein (mg/dL) | 0.04±0.21 | 0.06±0.24 | 0.592 |
| Ketones (mg/dL) | 0.14±0.57 | 0.10±0.34 | 0.328 |
| Glucose (mg/dL) | 0.01±0.10 | 0.04±0.34 | 0.053 |
| Bilirubin (mg/dL) | 0.24±0.65 | 0.22±0.63 | 0.814 |
| Blood (mg/dL) | 0.80±1.12 | 0.68±1.08 | 0.316 |
| Bilinogen (mg/dL) | 0.01±0.10 | 0.00±0.07 | 0.574 |
| Cotinine (ng/mL) | 673.8±1179.2 | 544.1±963.0 | 0.604 |
| Cr (mg/dL) | 131.9±82.5 | 138.4±69.0 | 0.394 |
*
p<0.05.
PV: positional vertigo, BMI: body mass index, Hb: hemoglobin, WBC: white blood cell, BUN: blood urea nitrogen, Cr: creatinine, GOT: 2.2 glutamate-oxaloacetate transaminase, GPT: 2.1 glutamate-pyruvate transaminase, TG: triglyceride, HDL: high-density lipoprotein, LDL: low-density lipoprotein, ALP: alkaline phosphatase, PTH: parathyroid hormone, SG: specific gravity